Pharmaceutical Labeling & Medical Marking Compliance

The contract requires precise compliance with Medical Marking Standard No. 1 for the labeling and marking of pharmaceutical packaging, ensuring all content, format, and durability meet stringent standards set by the Defense Logistics Agency and the Food and Drug Administration. The work involves applying permanent, legible, and tamper-resistant markings that adhere to regulatory specifications for identification, traceability, and safety throughout the supply chain, with attention to material resilience under varied environmental conditions. All labeling must be accurate, fully compliant, and consistently applied across all packaged pharmaceutical items intended for military and government use. The contract is classified as a subcontract under NAICS code 325992 and is issued by the Department of Defense through the Medical Supply Chain Pharm FSA. It was posted on August 2, 2026, with a firm response deadline of August 10, 2026. The place of performance and point of contact details are not specified, but performance is expected to support federal healthcare and logistics operations under DLA oversight. The procurement is open to qualified subcontractors capable of delivering fully auditable, compliant labeling solutions without deviation from established standards, and all submissions must align with the requirements enumerated in the DIBBS solicitation portal.